ClinConnect ClinConnect Logo
Search / Trial NCT06979778

Testing the Efficacy of the "Syd" App on Improving Quality of Life and Mental Health Among University Students in the Kingdom of Saudi Arabia

Launched by IAMYIAM LIMITED · May 12, 2025

Trial Information

Current as of June 28, 2025

Not yet recruiting

Keywords

Syd Qo L See Yourself Differently Quality Of Life M Health App Rct

ClinConnect Summary

This clinical trial is looking at whether using the "syd" app can help improve the quality of life and mental health for university students in Saudi Arabia. The researchers want to find out if the app can reduce feelings of anxiety and stress while also boosting positive feelings among students. To do this, they will compare students who use the app over three months with those who do not.

To participate in this study, you need to be at least 18 years old, a full-time medical student at Alfaisal University, and have a smartphone that can run the "syd" app. You'll be asked to fill out surveys about your quality of life and feelings during the trial. It’s important to note that students with severe mental health issues that could affect their ability to use the app will not be included in the study. This trial is not yet recruiting participants, but it aims to provide valuable insights into how technology can support student well-being.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age ≥ 18 years.
  • Enrolled as a full-time medical student at the Alfaisal university.
  • Owning a smartphone (iOS or Android) compatible with the "syd" app.
  • Willing to provide informed consent and comply with study procedures
  • Exclusion Criteria:
  • Known severe psychiatric or cognitive conditions that impede app usage
  • Inability to provide informed consent

About Iamyiam Limited

iamyiam limited is a biotechnology company focused on advancing innovative therapeutic solutions through rigorous clinical research and development. With a commitment to enhancing patient outcomes, the company specializes in leveraging cutting-edge technologies and scientific expertise to address unmet medical needs across various therapeutic areas. iamyiam limited is dedicated to maintaining the highest standards of clinical trial design and execution, ensuring the safety and efficacy of its products while fostering collaboration with healthcare professionals and regulatory bodies to bring transformative therapies to market.

Locations

Riyadh, , Saudi Arabia

Patients applied

0 patients applied

Trial Officials

Ahmed Abu-Zaid, MD

Principal Investigator

Alfaisal University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported